Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/1996
12/17/1996US5585400 Administering conjugated linoleic acid
12/17/1996US5585368 Skin disorders
12/17/1996US5585357 Heteroaryloxymethyl ketones as interleukin-1βconverting enzyme inhibitors
12/17/1996US5585103 Induction of cytotoxic T-lymphocyte responses
12/17/1996US5585100 Vaccine; diagnosis, therapy and prevention of disease
12/17/1996US5585097 Aglycosylated immunoglobulin g antibody; preventing renal allograft rejection
12/17/1996US5585089 Humanized immunoglobulins
12/17/1996CA2111461C 3-aminopiperidine derivatives and related nitrogen containing heterocycles
12/12/1996WO1996039524A1 Methods for enhancement of protective immune responses
12/12/1996WO1996039522A1 Human chemokine beta-11 and human chemokine alpha-1
12/12/1996WO1996039514A1 Method for prolonging the expression of a gene of interest using soluble ctla4 molecules
12/12/1996WO1996039511A2 A C5a-LIKE SEVEN TRANSMEMBRANE RECEPTOR
12/12/1996WO1996039503A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY AND METHODS FOR PREPARATION
12/12/1996WO1996039499A1 TNF-α RIBOZYMES, TNF-α RIBOZYME BINDING PROTEIN AND DEGRADATION RESISTANT mRNA DERIVATIVES LINKED TO TNF-α RIBOZYMES
12/12/1996WO1996039491A1 Recombinant poxvirus - cytomegalovirus compositions and uses
12/12/1996WO1996039442A1 G-protein receptor htnad29
12/12/1996WO1996039439A1 Human g-protein receptor hcegh45
12/12/1996WO1996039408A1 TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO[3,4-c]-1,2,4-TRIAZOLO[4,3-α]PYRIDINES
12/12/1996WO1996039400A1 Amino-substituted thiadiazoles, pyrimidines, triazines or triazoles useful as ctf receptor antagonists
12/12/1996WO1996039147A2 Topical ophthalmic formulations containing doxepin derivatives for treating allergic eye diseases
12/12/1996WO1996039142A1 Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride
12/12/1996WO1996039139A1 Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
12/12/1996WO1996033730A3 Chemokine binding protein and methods of use therefor
12/12/1996WO1996033282A3 High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations
12/12/1996CA2223421A1 Methods for enhancement of protective immune responses
12/12/1996CA2223307A1 Amino-substituted thiadiazoles, pyrimidines, triazines or triazoles useful as ctf receptor antagonists
12/12/1996CA2223282A1 Recombinant poxvirus - cytomegalovirus compositions and uses
12/12/1996CA2223038A1 A c5a-like seven transmembrane receptor
12/12/1996CA2222280A1 Human chemokine beta-11 and human chemokine alpha-1
12/12/1996CA2221706A1 G-protein receptor htnad29
12/12/1996CA2221637A1 Human g-protein receptor hcegh45
12/11/1996EP0747386A2 Method and antisense oligonucleotides to Interleukin-6 receptor mRNA for inhibiting cellular proliferation
12/11/1996EP0747347A1 RARy-specific retinobenzoic acid derivatives
12/11/1996EP0747345A2 Ethylamido fluorenes and improved method of making same
12/11/1996EP0746557A1 Intracellular signalling mediators
12/11/1996EP0746329A1 Anti-inflammatory factor, method of isolation, and use
12/11/1996EP0746320A1 Hiv protease inhibitors and intermediates
12/11/1996EP0655065B1 27-hydroxyrapamycin and derivatives thereof
12/11/1996CN1137799A Glucosamine disaccharides, method for their preparation pharmaceutical composition comprising same and their use
12/11/1996CN1137797A Rapamycin derivatives useful as immunosuppressants
12/11/1996CN1137758A Methods of prolonged suppression of humoral immunity
12/10/1996US5583242 Use of phosphotyrosine phosphatase inhibitors for controlling cellular proliferation
12/10/1996US5583222 Antiinflammatory agents for treatment of skin disorders
12/10/1996US5583202 Antigenized antibodies and genes
12/10/1996US5583152 Method for treating vasospastic cardiovascular diseases heterocyclic amide derivatives
12/10/1996US5583143 Administering a 2,3-diaryl-1-benzopyran
12/10/1996US5583139 Marcolide immunomodulators
12/10/1996US5583135 Heterotricyclic derivatives, process for their preparation and pharmaceutical compositions containing them
12/10/1996US5583125 25-Carboxylic acid derivatives in the vitamin D series, process for their production, intermediate products for these processes, pharmaceutical preparations containing these derivatives as well as their use for the production of pharmaceutical agents
12/10/1996US5583117 Acylated uridine and cytidine for elevating tissue uridine and cytidine
12/10/1996US5583109 Method of stimulating immune response
12/10/1996US5583105 Oral pharmaceutical preparation
12/10/1996US5583018 Rapamycin derivative process for its preparation and its use
12/10/1996US5582995 Methods of screening for compounds which inhibit the direct binding of Ras to Raf
12/10/1996US5582172 Intravascular administering a particle carrier comprising an organic inner core surface grafted with carbohydrates specific bonding to lymph nodes
12/10/1996CA2114727C Quinoline derivatives as immunostimulants
12/10/1996CA1338781C Ligands and methods for augmenting b-cell proliferation
12/10/1996CA1338776C Use of transglutaminases as immunosuppressants
12/07/1996CA2175854A1 Rar(gamma)-specific retinobenzoic acid derivatives
12/05/1996WO1996038559A1 Chemokine n-terminal deletion mutations
12/05/1996WO1996038550A1 A novel form of dipeptidylpeptidase iv (cd26) found in human serum, antibodies thereto, and uses therefor
12/05/1996WO1996038457A1 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor
12/05/1996WO1996038436A1 (2-thienyl)alkanoic acid derivatives
12/05/1996WO1996038434A1 Tricyclic inhibitors of matrix metalloproteinases
12/05/1996WO1996038426A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
12/05/1996WO1996038164A1 Serum immunoregulatory polypeptides and uses therefor
12/05/1996WO1996038154A1 Means for treating radiation injuries
12/05/1996WO1996038150A1 4.4-(disubstituted)cyclohexan-1-ols-monomers and related compounds
12/05/1996WO1996038142A1 1h-4(5)-substituted imidazole derivatives
12/05/1996WO1996034953A3 Cd16-ii variants
12/05/1996DE19513595C1 Antikörper gegen Herzmuskel-Actin Antibodies against heart muscle actin
12/05/1996CA2223276A1 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor
12/05/1996CA2222863A1 Serum immunoregulatory polypeptides and uses therefor
12/05/1996CA2222561A1 4.4-(disubstituted)cyclohexan-1-ols-monomers and related compounds
12/05/1996CA2222539A1 Agent for the treatment of radiation injuries
12/05/1996CA2222419A1 A novel form of dipeptidylpeptidase iv (cd26) found in human serum, antibodies thereto, and uses therefor
12/05/1996CA2222147A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
12/05/1996CA2222099A1 1h-4(5)-substituted imidazole derivatives
12/05/1996CA2220040A1 Tricyclic inhibitors of matrix metalloproteinases
12/04/1996EP0745611A1 Interleukin-4 and Interleukin-1beta synergistically induce VCAM-1
12/04/1996EP0745136A1 B7-1-specific ligands, and their use for the induction of t cell anergy
12/04/1996EP0745094A1 Superagonists and antagonists of h il-6, and 3d modelling method for their selection
12/04/1996EP0745083A1 2-HETEROARYL-5,11-DIHYDRO-6H-DIPYRIDO [3,2-b:2',3'-e][1,4]DIAZEPINES AND THEIR USE IN THE PREVENTION OR TREATMENT OF HIV INFECTION
12/04/1996EP0745075A1 6-substituted mycophenolic and derivatives with immunosuppressive activity
12/04/1996EP0745074A1 4-amino derivatives of mycophenolic acid with immunosuppressant activity
12/04/1996EP0745073A1 5-substituted derivatives of mycophenolic acid
12/04/1996EP0745072A1 4-amino derivatives of 5-substituted mycophenolic acid
12/04/1996EP0745071A1 4-amino 6-substituted mycophenolic acid and derivatives with immunosuppressive activity
12/04/1996EP0745063A1 Substituted biphenyl derivatives as phosphodiesterase inhibitors
12/04/1996EP0744957A1 Composition and method for preventing and treating inflammation with immunoglobulin a
12/04/1996EP0744948A1 Protease inhibitors
12/04/1996CN1137275A O-aryl O-alkyl O-alkenyl and O-alkynyl-macrolides having immunosuppressive activity
12/04/1996CN1137274A 6-oxo-nucleosides useful as immunosuppressants
12/04/1996CN1137268A Amidino derivatives useful as nitric oxide synthase inhibitors
12/04/1996CN1033451C Alpha-substituted benzenemethanamine derivatives
12/03/1996US5581011 Antihistamine intermediates
12/03/1996US5580989 Antiallergens, antiinflammatory agents
12/03/1996US5580878 Treating sleep disorders
12/03/1996US5580860 Pharmaceutical composition containing 2-amino-6-chloropurine-9-β-D-2',3'-dideoxyribofuranoxside
12/03/1996US5580780 Vascular adhesion protein-(VAP-1) and VAP-1-specific antibodies
1 ... 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 ... 1172